# REVTORPYK
> **NDA219908** · New Drug Application · Sponsor: CELCUITY · Approved 2026-07-14
## Drug
- **FDA Application Number:** NDA219908
- **Application type:** New Drug Application
- **Brand name:** REVTORPYK
- **Generic name:** Gedatolisib
- **Active ingredients:** GEDATOLISIB
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CELCUITY
- **First approval:** 2026-07-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219908)
---
*MORVS · CC0 1.0*